Oridonin attenuates low shear stress-induced endothelial cell dysfunction and oxidative stress by activating the nuclear factor erythroid 2-related factor 2 pathway

BACKGROUND: Atherosclerosis (AS) is the primary cause of cardiovascular disease and the incidence is extremely common; however, there are currently few drugs that can effectively treat AS. Although oridonin has been widely used to treat inflammation and cancer for numerous years, to the best of our...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhipeng, Liu, Heqian, Zhao, Xiaoqi, Mamateli, Subinur, Liu, Cheng, Wang, Lei, Yu, Jing, Liu, Yutong, Cai, Jing, Qiao, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261036/
https://www.ncbi.nlm.nih.gov/pubmed/35799227
http://dx.doi.org/10.1186/s12906-022-03658-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261036/
https://www.ncbi.nlm.nih.gov/pubmed/35799227
http://dx.doi.org/10.1186/s12906-022-03658-2

Ejemplares similares